Expert Pitch
University of Miami Health System, Miller School of Medicine

[email protected] pediatrician @LisaGwynn, incoming president of #Florida chapter of the @AmerAcadPeds helped issue new guidance on #reopeningschools calling for safety and science to drive decisions.

Lisa Gwynn, D.O., M.B.A., is associate professor of Clinical Pediatrics and Public Health Sciences at the University of Miami Health Sytem, Miller School of Medicine (UMMSOM) and serves as Medical Director for the Pediatric Mobile Clinic, a program that provides a medical home care to uninsured children, as well as Program Director for the School Health Initiative consisting of nine pediatric clinics in Miami-Dade County schools. She currently sits on the school re-opening advisory committee for Miami-Dade County Public Schools' Superintendent, Alberto Carvalho. 

Dr. Gwynn is currently the vice-president and incoming president of the Florida Chapter for the American Academy of Pediatrics.

Dr. Gwynn also is the Director of Innovation and Community Engagement for the Mailman Center for Child Development at the University of MIami and leads efforts to implement telemedicine programs within the center.  She serves as Associate Division Chief of the Division of General Pediatrics at UMMSOM.

Her areas of interest include community pediatrics, telemedicine, school health, advocacy and healthcare delivery in underserved populations. She plays a large role in educating pediatric residents, medical, nursing and public health students on the complexities of caring for immigrant and underserved populations and how the social determinants of health play a large role in the well-being of children. 

Dr. Gwynn is a Certified Physician Executive, Board Certified in Pediatrics and a Fellow of the American Academy of Pediatrics. She remains steadfast in serving her community and is a passionate advocate for kids, especially those children who are most marginalized in our society.

EDUCATION: 

She received her medical degree from NSU College of Osteopathic Medicine and completed her postgraduate medical training in Pediatrics at the University of Miami/Jackson Memorial Hospital in Miami, Florida. She worked in private practice for 9 years and joined the faculty at UMMSOM in 2010. In 2011, she earned her MBA, with a specialization in Health Sector Management and Policy from the University of Miami School of Business. 

 

Lisa Gwynn, D.O., M.B.A. is an associate professor of clinical pediatrics and public health sciences at the University of Miami Health System and director of the Pediatric Mobile Clinic and the Dr. John T. Macdonald Foundation Miami-Dade Public School Health Initiative.She is also part of the advisory council on the reopening of schools for Miami-Dade County Public School Superintendent, Alberto Carvalho. 

 

 



Filters close

Showing results

110 of 6110
Released: 2-Aug-2021 6:05 PM EDT
Rethinking Remdesivir
University of California San Diego Health

UC San Diego researchers modify remdesivir, creating oral version that can be taken earlier in COVID-19 diagnoses. In cell and animal studies, revised drug proved effective and safe.

Newswise: Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Released: 2-Aug-2021 4:25 PM EDT
Researchers from Hackensack Meridian University Medical Center and Colleagues Develop New Model to Help Clinicians Predict Risk of Death in Patients Hospitalized with COVID-19
Hackensack Meridian Health

New COVID-19 40-day mortality risk model, published in The Public Library of Science ONE, has potential for use in patient treatment planning, comparisons of therapeutic strategies, and public-health preparations.

Released: 2-Aug-2021 4:05 PM EDT
Town Hall on Effectiveness of COVID-19 Vaccination in Immunosuppressed Patients Hosted by the American College of Rheumatology
American College of Rheumatology (ACR)

How effective COVID-19 vaccines have been in immunosuppressed and rheumatic disease patients remains an incompletely answered question. The American College of Rheumatology (ACR) has organized an expert panel to share what we are learning from real-world data and answer questions.

Released: 2-Aug-2021 2:00 PM EDT
CDC withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test does not mean the test failed
Newswise

Social media is now rife with claims about why the CDC is withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test after December 2021.

Newswise: Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Released: 2-Aug-2021 1:30 PM EDT
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19
Argonne National Laboratory

Scientists using the Advanced Photon Source have discovered that a drug used to fight tumors in animals might be effective against many types of coronaviruses, including SARS-CoV-2.

Released: 2-Aug-2021 11:25 AM EDT
Award-Winning Journalist and CDC Principal Investigator to Serve as ACR Convergence 2021 Keynote Speaker
American College of Rheumatology (ACR)

Convergence 2021, the annual meeting of the American College of Rheumatology (ACR), returns to a virtual meeting platform Nov. 1 - 10. This year’s meeting will include presentations from over 320 clinicians, researchers and health experts, including this year’s keynote speaker, Dr. Seema Yasmin.

Newswise: COVID-19: Small Sign of Hope as Vaccinations Rise
Released: 2-Aug-2021 10:45 AM EDT
COVID-19: Small Sign of Hope as Vaccinations Rise
Cedars-Sinai

As COVID-19 cases spike in Los Angeles and throughout the Golden State, driven by the spread of the delta variant among unvaccinated residents, there may be a small sign of hope: More people are finally getting their shot.

Newswise: New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
Released: 31-Jul-2021 10:05 AM EDT
New Evidence Shows the COVID-19 Delta Variant Rapidly Rising
University of Miami Health System, Miller School of Medicine

The University’s coronavirus sequencing effort uncovered that there are several variants present in its patient population, but Delta is chief among them and easily transmitted. And its presence is likely triggering a local surge in the infectious disease. University of Miami researchers and physicians are seeing firsthand how rapidly the Delta variant of COVID-19 is spreading through the local population.

Released: 30-Jul-2021 2:05 PM EDT
Thinking Impaired in 60% of COVID-19 Survivors, Study Finds
University of Texas Health Science Center at San Antonio

In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San Antonio reported July 29 at the Alzheimer’s Association International Conference.


Showing results

110 of 6110

close
1.1599